Spanish doctors developed a new treatment for endometrial cancer that prolongs fertility and has fewer side effects than similar treatments, according to a report published in the Annals of Oncology.
The study showed that an intrauterine device that releases the progesterone-like hormone levonorgestrel, when paired with gonadotropin-releasing hormone, is effective at halting and reversing the growth of the uterine cancers.